Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Urinary tract infection (lower) - men - Management
View full scenario

How should I manage lower urinary tract infection in a man with an indwelling catheter?

  • Follow local guidelines, when these are available.
  • Do not treat asymptomatic bacteriuria.
  • Considerable clinical judgement is required to diagnose urinary tract infection (UTI) in men with an indwelling urinary catheter.
  • If symptoms are severe (for example severe nausea and vomiting, confusion, tachypnoea, tachycardia, hypotension, reduced urine output), admit the person to hospital; intravenous antibiotics may be required.
  • Check that the catheter is correctly positioned and is not blocked. If the catheter has been in place for more than a week, consider changing it before starting antibiotic treatment.
  • If there is fever or loin pain (or both), manage as upper UTI. See the CKS topic on Pyelonephritis - acute.
  • Otherwise, treat for lower UTI:
    • Relieve symptoms with paracetamol or ibuprofen.
    • Before starting antibiotic treatment, obtain a urine sample for culture and microscopy.
    • Treat with an antibiotic for 7 days.
    • If symptoms are mild, consider withholding antibiotics until the result of urine culture is available to guide choice of antibiotic.
    • If treatment cannot wait for the culture results, start empirical treatment with trimethoprim or nitrofurantoin.
      • Trimethoprim 200 mg twice daily, for 7 days. Trimethoprim should not be used for empirical treatment if the man has a history of recurrent infections or has taken trimethoprim within the past 12 months.
      • Nitrofurantoin 50 mg four times daily, or 100 mg (modified-release) twice daily, for 7 days. The standard formulation is suitable for most people. Consider prescribing the modified-release formulation if nausea has previously been troublesome with the standard formulation, or if adherence with taking medication four times daily is likely to be poor.
    • Follow up after 48 hours (or according to the clinical situation) to check response to treatment and the urine culture results.

In depth

How can I prevent urinary tract infections in men with indwelling catheters?

  • Ensure an indwelling urinary catheter is appropriate.
    • Use an indwelling catheter only after alternative methods of management have been considered.
    • Regularly review the clinical need for catheterization and remove the catheter as soon as possible.
    • Use intermittent catheterization in preference to an indwelling catheter if this is clinically appropriate and is a practical option for the person.
  • Prevent the introduction of infection.
    • Healthcare personnel should be trained and assessed in their competence to perform urethral catheterization using aseptic procedures.
    • Urine samples should be obtained from a sampling port using an aseptic technique.
    • Catheters should be changed only when clinically necessary (for example to prevent blockage), or according to the manufacturer's recommendations.
    • When changing catheters, antibiotic prophylaxis should only be used for people with a history of catheter-associated urinary tract infection following catheter change.
  • Do not use:
    • Bladder instillations or washouts.
    • Prophylactic antibiotics when changing catheters in men with a heart valve lesion, septal defect, patent ductus, or prosthetic valve.
    • Topical antiseptics or antibiotics applied to the catheter, urethra, or meatus — daily washing of the meatus with soap and water is sufficient.

In depth

How should I follow up a catheterized man with lower urinary tract infection?

  • Review after 48 hours, or according to the clinical situation, to ensure the man is responding to treatment, and to check the results of the urine culture.
  • If urine culture shows that the organism is resistant to the current antibiotic, and:
    • If symptoms have not resolved, change to an antibiotic that the organism is sensitive to.
    • If symptoms have resolved, consider continuing with the current antibiotic.
      • If symptoms recur, start treatment with an antibiotic shown in the laboratory report to cover the infecting organism.
  • If the man fails to respond to two courses of antibiotic shown by urine culture to be appropriate treatment, and compliance has been good, consider referring for assessment and investigation.

In depth

When should I refer a catheterized man with lower urinary tract infection?

  • Consider referring for assessment and investigation if the man fails to respond to two courses of antibiotic shown by urine culture to be appropriate treatment, and treatment adherence has been verified.
  • If cancer is suspected, refer urgently. Refer the man to a team specializing in the management of urological cancer if:
    • He is of any age, with macroscopic haematuria and urine culture fails to confirm a urinary tract infection (UTI) or the haematuria does not resolve with treatment of a UTI. 
    • He is 40 years of age or older, and presents with recurrent or persistent UTI associated with haematuria.
    • He is 50 years of age or older, and has unexplained microscopic haematuria — exclude causes such as the urinary catheter and infection.
    • An abdominal mass is identified (clinically or on imaging) that is thought to arise from the urinary tract.
  • If there is persistent microscopic haematuria, and this is not thought to be caused by a urinary catheter:
    • Refer for urological assessment those men younger than 50 years of age who do not have proteinuria or raised serum creatinine.
    • Refer for renal assessment those men with proteinuria or raised serum creatinine.

In depth

Prescriptions

Analgesia: use when required

Age from 16 years onwards
Ibuprofen tablets: 200mg to 400mg three to four times a day
Ibuprofen 200mg tablets
Take one or two tablets 3 to 4 times a day when required for pain relief. Do not exceed the stated dose.
Supply 56 tablets.
Age: from 16 years onwards
NHS cost: £1.38
OTC cost: £2.38
Licensed use: yes
Paracetamol tablets: 500mg to 1g up to four times a day
Paracetamol 500mg tablets
Take one or two tablets every 4 to 6 hours when required for pain relief. Maximum of 8 tablets in 24 hours.
Supply 50 tablets.
Age: from 16 years onwards
NHS cost: £0.78
OTC cost: £1.35
Licensed use: yes

Trimethoprim or nitrofurantoin for 7 days

Age from 14 years onwards
Nitrofurantoin capsules: 50mg four times a day for 7 days
Nitrofurantoin 50mg capsules
Take one capsule four times a day for 7 days.
Supply 28 capsules.
Age: from 14 years onwards
NHS cost: £2.32
Licensed use: yes
Patient information: This medicine may cause your urine to turn more yellow than normal.
Age from 16 years onwards
Nitrofurantoin tablets: 50mg four times a day for 7 days
Nitrofurantoin 50mg tablets
Take one tablet four times a day for 7 days.
Supply 28 tablets.
Age: from 16 years onwards
NHS cost: £2.83
Licensed use: yes
Patient information: This medicine may cause your urine to turn more yellow than normal.
Nitrofurantoin m/r caps: 100mg twice a day for 7 days
Nitrofurantoin 100mg modified-release capsules
Take one capsule twice a day for 7 days.
Supply 14 capsules.
Age: from 16 years onwards
NHS cost: £4.89
Licensed use: yes
Patient information: This medicine may cause your urine to turn more yellow than normal.
Trimethoprim tablets: 200mg twice a day for 7 days
Trimethoprim 200mg tablets
Take one tablet twice a day for 7 days.
Supply 14 tablets.
Age: from 16 years onwards
NHS cost: £0.91
Licensed use: yes

© NHS Institute for Innovation and Improvement